| Proteins and DNA elements essential for the CRISPR adaptation process in Escherichia coli I Yosef, MG Goren, U Qimron Nucleic acids research 40 (12), 5569-5576, 2012 | 839 | 2012 |
| CRISPR adaptation biases explain preference for acquisition of foreign DNA A Levy, MG Goren, I Yosef, O Auster, M Manor, G Amitai, R Edgar, ... Nature 520 (7548), 505-510, 2015 | 429 | 2015 |
| Transfer of carbapenem-resistant plasmid from Klebsiella pneumoniae ST258 to Escherichia coli in patient MG Goren, Y Carmeli, MJ Schwaber, I Chmelnitsky, V Schechner, ... Emerging infectious diseases 16 (6), 1014, 2010 | 176 | 2010 |
| Extending the host range of bacteriophage particles for DNA transduction I Yosef, MG Goren, R Globus, S Molshanski-Mor, U Qimron Molecular cell 66 (5), 721-728. e3, 2017 | 144 | 2017 |
| High-temperature protein G is essential for activity of the Escherichia coli clustered regularly interspaced short palindromic repeats (CRISPR)/Cas system I Yosef, MG Goren, R Kiro, R Edgar, U Qimron Proceedings of the National Academy of Sciences 108 (50), 20136-20141, 2011 | 133 | 2011 |
| Molecular Epidemiology, Sequence Types, and Plasmid Analyses of KPC-Producing Klebsiella pneumoniae Strains in Israel A Leavitt, Y Carmeli, I Chmelnitsky, MG Goren, I Ofek, S Navon-Venezia Antimicrobial agents and chemotherapy 54 (7), 3002-3006, 2010 | 114 | 2010 |
| DNA motifs determining the efficiency of adaptation into the Escherichia coli CRISPR array I Yosef, D Shitrit, MG Goren, D Burstein, T Pupko, U Qimron Proceedings of the National Academy of Sciences 110 (35), 14396-14401, 2013 | 77 | 2013 |
| Experimental Definition of a Clustered Regularly Interspaced Short Palindromic Duplicon in Escherichia coli MG Goren, I Yosef, O Auster, U Qimron Journal of molecular biology 423 (1), 14-16, 2012 | 58 | 2012 |
| Sensitizing pathogens to antibiotics using the CRISPR-Cas system M Goren, I Yosef, U Qimron Drug Resistance Updates 30, 1-6, 2017 | 56 | 2017 |
| Plasmid-encoded OXA-48 carbapenemase in Escherichia coli from Israel MG Goren, I Chmelnitsky, Y Carmeli, S Navon-Venezia Journal of antimicrobial chemotherapy 66 (3), 672-673, 2011 | 56 | 2011 |
| Carbapenem-Resistant KPC-2-Producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008 MG Goren, S Navon-Venezia, I Chmelnitsky, Y Carmeli Antimicrobial agents and chemotherapy 54 (6), 2687-2691, 2010 | 47 | 2010 |
| Repeat size determination by two molecular rulers in the type IE CRISPR array MG Goren, S Doron, R Globus, G Amitai, R Sorek, U Qimron Cell reports 16 (11), 2811-2818, 2016 | 39 | 2016 |
| The bacterial CRISPR/Cas system as analog of the mammalian adaptive immune system M Goren, I Yosef, R Edgar, U Qimron RNA biology 9 (5), 549-554, 2012 | 37 | 2012 |
| Rapid seroconversion and persistent functional IgG antibodies in severe COVID-19 patients correlates with an IL-12p70 and IL-33 signature A Munitz, L Edry-Botzer, M Itan, R Tur-Kaspa, D Dicker, D Marcoviciu, ... Scientific Reports 11 (1), 3461, 2021 | 36 | 2021 |
| Full shut-off of Escherichia coli RNA-polymerase by T7 phage requires a small phage-encoded DNA-binding protein A Tabib-Salazar, B Liu, A Shadrin, L Burchell, Z Wang, Z Wang, ... Nucleic acids research 45 (13), 7697-7707, 2017 | 22 | 2017 |
| CRISPR adaptation in Escherichia coli subtypeI-E system R Kiro, MG Goren, I Yosef, U Qimron Biochemical Society Transactions 41 (6), 1412-1415, 2013 | 18 | 2013 |
| Programming bacteriophages by swapping their specificity determinants MG Goren, I Yosef, U Qimron Trends in microbiology 23 (12), 744-746, 2015 | 17 | 2015 |
| A phage mechanism for selective nicking of dUMP-containing DNA T Mahata, S Molshanski-Mor, MG Goren, B Jana, M Kohen-Manor, I Yosef, ... Proceedings of the National Academy of Sciences 118 (23), e2026354118, 2021 | 10 | 2021 |
| SARS-CoV-2 serological testing using electrochemiluminescence reveals a rapid onset of seroconversion in severe COVID-19 patients A Munitz, L Edry-Botzer, M Itan, R Tur-Kaspa, D Dicker, D Markovitch, ... medRxiv, 2020.06. 28.20141838, 2020 | 3 | 2020 |
| Using the CRISPR-Cas system to positively select mutants in genes essential for its function I Yosef, MG Goren, R Edgar, U Qimron CRISPR: Methods and Protocols, 233-250, 2015 | 3 | 2015 |
